scispace - formally typeset
Open AccessJournal ArticleDOI

Macular telangiectasia type 2

Reads0
Chats0
TLDR
The current knowledge on macular telangiectasia type 2 is summarized, including the epidemiology, the genetics, the clinical findings, the staging and the differential diagnosis of the disease.
About
This article is published in Progress in Retinal and Eye Research.The article was published on 2013-05-01 and is currently open access. It has received 300 citations till now. The article focuses on the topics: Macular telangiectasia & Microperimetry.

read more

Citations
More filters
Journal ArticleDOI

Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications.

TL;DR: The methods used to create OCTA images, the practical applications of OCTA in light of invasive dye‐imaging studies (e.g. fluorescein angiography) and clinical studies demonstrating the utility of OCT a for research and clinical practice are discussed.
Journal ArticleDOI

Mechanisms of macular edema: Beyond the surface.

TL;DR: This comprehensive review on the current understanding of macular edema and its mechanisms opens perspectives to identify new preventive and therapeutic strategies for this sight-threatening condition.
Journal ArticleDOI

Lutein, Zeaxanthin, and meso-Zeaxanthin: The Basic and Clinical Science Underlying Carotenoid-based Nutritional Interventions against Ocular Disease

TL;DR: The chemistry, biochemistry, biophysics, and physiology of these yellow pigments that are specifically concentrated in the macula lutea are examined through the means of high-affinity binding proteins and specialized transport and metabolic proteins where they play important roles as short-wavelength light-absorbers and localized, efficient antioxidants in a region at high risk for light-induced oxidative stress.
References
More filters
Journal ArticleDOI

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

TL;DR: To report 24-month vision and fluorescein angiographic outcomes from trials evaluating photodynamic therapy with verteporfin (Visudyne) in patients with subfoveal choroidal neovascularization caused by age-related macular degeneration (AMD).
Book

Müller Cells in the Healthy and Diseased Retina

TL;DR: A proper understanding of the gliotic responses of Müller cells in the diseased retina, and of their protective vs. detrimental effects, is essential for the development of efficient therapeutic strategies that use and stimulate the neuron-supportive/protective-and prevent the destructive-mechanisms of gliosis.

Treatment of age-related macular degeneration with photodynamic therapy (tap) study group. photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2

N M Bressler
TL;DR: The visual acuity benefits of verteporfin therapy for AMD patients with predominantly classic CNV subfoveal lesions are safely sustained for 2 years, providing more compelling evidence to use Vertepor Fin therapy for these cases.
Journal ArticleDOI

Histology of the Human Eye.

TL;DR: A classic is born that will most likely become a standard reference and teaching text throughout the world after an introductory chapter on cell structure and 11 chapters approach the human eye from the viewpoint of gross anatomy, physiology, biochemistry, embryology, light and electron microscopy.
Journal ArticleDOI

Adaptive optics scanning laser ophthalmoscopy

TL;DR: The first scanning laser ophthalmoscope that uses adaptive optics to measure and correct the high order aberrations of the human eye is presented, permitting axial sectioning of retinal tissue in vivo.
Related Papers (5)